Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Granel

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The British Journal of Dermatology|November 28, 2024
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world settingKarine Billard, Laurent Mortier, Olivier Dereure, et al.
JAMA Dermatology|July 16, 2020
Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic MelanomaAngélique Brunot, Jean-Jacques Grob, Geraldine Jeudy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 25, 2025
Brain metastases from Merkel cell carcinoma: A nationwide retrospective studyRaphaëlle Caillot, Astrid Blom, Céleste Lebbé, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in FranceMarguerite Kandel, Aurélie Bardet, Stéphane Dalle, et al.
Cancer|October 23, 2019
Quality-of-life assessment in French patients with metastatic melanoma in real lifeMarguerite Kandel, Stéphane Dalle, Aurélie Bardet, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2026
Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCACaroline Robert, Emilie Gérard, Emilie Lanoy, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The British Journal of Dermatology|November 28, 2024
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world settingKarine Billard, Laurent Mortier, Olivier Dereure, et al.
JAMA Dermatology|July 16, 2020
Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic MelanomaAngélique Brunot, Jean-Jacques Grob, Geraldine Jeudy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 25, 2025
Brain metastases from Merkel cell carcinoma: A nationwide retrospective studyRaphaëlle Caillot, Astrid Blom, Céleste Lebbé, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in FranceMarguerite Kandel, Aurélie Bardet, Stéphane Dalle, et al.
Cancer|October 23, 2019
Quality-of-life assessment in French patients with metastatic melanoma in real lifeMarguerite Kandel, Stéphane Dalle, Aurélie Bardet, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2026
Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCACaroline Robert, Emilie Gérard, Emilie Lanoy, et al.
Pageof 4